Salarius Pharmaceuticals (NASDAQ:SLRX) Stock Price Up 1.3% – Here’s What Happened

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX)’s stock price rose 1.3% during trading on Monday . The stock traded as high as $1.60 and last traded at $1.57. Approximately 62,855 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 711,689 shares. The stock had previously closed at $1.55.

Salarius Pharmaceuticals Trading Up 1.3 %

The company’s 50-day simple moving average is $1.52 and its 200 day simple moving average is $1.91. The stock has a market cap of $2.26 million, a P/E ratio of -0.19 and a beta of 0.92.

About Salarius Pharmaceuticals

Salarius Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma.